NIH-funded research R01 grant

Understanding how Pseudomonas bacteria resist antibiotics

Official title: Regulation and mechanism of RND-mediated antibiotic efflux in Pseudomonas

Funded at Emory University · NIH-11110381 · Data updated 2026-11-12

This study is looking at how a common bacteria called Pseudomonas aeruginosa becomes resistant to antibiotics by using special proteins to push the medicine out, and it aims to find new ways to fight these tough infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startJune 10, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$647,684
NIH project number5R01AI185192-02
Project IDNIH-11110381 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant Pseudomonas aeruginosa.

Less likely to help

Patients with infections caused by bacteria other than Pseudomonas aeruginosa may not benefit from this research.

What this research studies

This research investigates the mechanisms by which the bacteria Pseudomonas aeruginosa develops resistance to antibiotics, particularly focusing on a specific group of proteins known as RND efflux pumps. These pumps help the bacteria expel antibiotics, making infections harder to treat. The study aims to uncover how these pumps are regulated and how they select which antibiotics to expel, which could lead to new strategies for overcoming antibiotic resistance. By collaborating with a team of researchers, the project will utilize advanced techniques to analyze the structure and function of these efflux systems.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively combat antibiotic-resistant infections, improving outcomes for patients.

How similar studies have gone: Previous research has shown success in understanding antibiotic resistance mechanisms, but this specific approach to studying RND efflux pumps is relatively novel.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Dunham, Christine M — Emory University
  • Study coordinator: Dunham, Christine M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.